iSpecimen
Update in progressISPC (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
iSpecimen Inc. runs an online marketplace that connects life science researchers with hospitals, labs, and other providers of human biospecimens. The platform offers biofluids such as blood, plasma, serum, urine, saliva, sputum, nasopharyngeal samples, and CSF; solid tissues (fresh, fixed, frozen, FFPE blocks and slides); and hematopoietic/immune cells (bone marrow, cord blood, PBMCs). Customers include biopharma, IVD firms, and government or academic institutions. Founded 2009, based in Woburn, MA.
Company score
- Sentiment
- 0.23
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- 0.02
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.01
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.12
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!